Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma
Join Prashant Kapoor, MD and Shaji Kumar, MD from Mayo Clinic Cancer Center as they present their expertise on a range of cases pertaining to multiple myeloma.
Many factors need to be considered when determining the optimal multiple myeloma (MM) treatment: age, prognostic factors, comorbidities, toxicity profiles, response to prior therapy and previous relapses. Moreover, a variety of available supportive care measures targeting adverse symptoms related to MM or MM therapy have to be tailored to a specific patient. Therefore, the key in maximizing positive treatment and supportive care outcomes for patients with MM lies in careful choice of individualized treatment regimens along with early recognition and management of treatment or MM-associated adverse events. It is critical that health care providers are up-to-date with the most current evidence-based recommendations to be able to make best practice decisions in this complex environment.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, case managers, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Evaluate the multidisciplinary aspects and key clinical considerations to optimize diagnosis and management of patients with multiple myeloma.
- Enhance awareness of new evidence-based therapeutic options for multiple myeloma.
- Tailor supportive care measures to individual patients.
Prashant Kapoor, MD
Mayo Clinic Cancer Center
Shaji Kumar, MD
Mayo Clinic Cancer Center
Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.
The faculty listed below have disclosed the following relevant financial relationships:
Prashant Kapoor, MD, FACP
Amgen Inc.: Grant/Research Support
Celgene Corporation: Grant/Research Support
sanofi-aventis U.S.: Scientific Advisor
Takeda Pharmaceuticals North America, Inc.: Grant/Research Support
Shaji K. Kumar, MD
Abbott Laboratories: Grant/Research Support
Amgen Inc.: Grant/Research Support; Scientific Advisor
Bristol-Myers Squibb Company: Scientific Advisor
Celgene Corporation: Grant/Research Support; Scientific Advisor
GlycoMimetics: Scientific Advisor
Janssen Pharmaceutica Products, LP: Grant/Research Support; Scientific Advisor
Kesios Therapeutics: Consulting Fees, Honoraria
Novartis Pharmaceuticals Corporation: Grant/Research Support
NOXXON Pharma AG: Consulting Fees, Honoraria
sanofi-aventis U.S.: Grant/Research Support; Scientific Advisor
SkylineDx: Consulting Fees, Honoraria
Takeda Pharmaceuticals North America, Inc.: Grant/Research Support; Scientific Advisor
The activity planning staff listed below has no relevant financial relationships to disclose:
Mark Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Karen Kanefield; Joan S. McClure, MS; Diane McPherson; Melanie Moletzsky; Deborah Moonan, RN, BSN; Lisa Perfidio; Liz Rieder; Shannon K. Ryan; Kathy Smith; Jennifer McCann Weckesser
The NCCN clinical information team listed below, who have reviewed content, has no relevant financial relationships to disclose:
Rashmi Kumar, PhD; Dorothy Shead, MS
The ACCME/ANCC/ACPE defines “conflict of interest” as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.
ACCME, ACPE, and ANCC focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CE activity. ACCME, ACPE, and ANCC have not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME, ACPE, and ANCC defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.
All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation to the tasks and methods of delivery.
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.
National Comprehensive Cancer Network designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. NCCN designates this educational activity for a maximum of 0.82 contact hours. Accreditation as a provider refers to the recognition of educational activities only; accredited status does not imply endorsement by NCCN or ANCC of any commercial products discussed/displayed in conjunction with the educational activity.
Kristina M. Gregory, RN, MSN, OCN, is our lead nurse planner for this educational activity.
|National Comprehensive Cancer Network is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
Type of Activity: Knowledge
National Comprehensive Cancer Network designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of continuing education credit in states that recognize ACPE accredited providers.
Universal Activity Number: 0836-0000-16-121-H01-P
- 0.75 ACPE contact hours
- 0.75 AMA PRA Category 1 Credit™
- 0.82 ANCC contact hours
- 0.75 Participation
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
- Adobe Reader or other PDF reader software for certificate viewing/printing